Literature DB >> 16524773

Serological diagnosis and follow-up of asymptomatic and acute Q fever infections.

Christiane Wagner-Wiening1, Stefan Brockmann, Peter Kimmig.   

Abstract

During an outbreak of Q fever at a farmer's market in Soest (North Rhine-Westphalia, Germany) in 2003, we examined 263 serum samples of presumably infected persons for Q fever antibodies. One hundred and seventy-one of these patients were tested positive for acute Q fever infection. Furthermore, 29 persons of certain risk groups like pregnant women (n=11) or patients with valvular heart disease (n=18) were examined. Among these, in four pregnant women and two heart patients an acute but asymptomatic infection could be diagnosed. With 30 patients we performed a serological follow-up for 8-60 weeks. In our study, phase 2 (PH2)-IgM antibodies as a marker for acute infection were present in all 30 patients 3-4 weeks after onset of clinical signs and disappeared 3-4 months later. Six weeks to three months after clinical manifestation, all patients developed PH1-IgG antibodies in low levels with no clinical signs of chronic Q fever. Three patients, including one pregnant woman showed high-level titres and were treated for chronic Q fever. Eleven patients with low PH1-IgG antibodies and all three patients with high titres developed IgA antibodies from 10 weeks after clinical manifestation; therefore PH1-IgA cannot be used as the only serological marker for chronic Q fever. Chronic infections were indicated only by a continuous increase of PH1 antibodies and a high persistence of PH2-IgG. We therefore conclude that the exclusion of chronic Q fever infection by a single serological examination cannot be done. At least three consecutive tests should be performed, that is 3, 6, and 9 months after initial Q fever infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524773     DOI: 10.1016/j.ijmm.2006.01.045

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  6 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection.

Authors:  J C J P Hagenaars; N H M Renders; A S van Petersen; S O A Shamelian; M G L de Jager-Leclercq; F L Moll; P C Wever; O H J Koning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

3.  Acute Q fever in Portugal. Epidemiological and clinical features of 32 hospitalized patients.

Authors:  Carolina Palmela; Robert Badura; Emília Valadas
Journal:  Germs       Date:  2012-06-01

4.  Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.

Authors:  C C H Wielders; L M Kampschreur; P M Schneeberger; M M Jager; A I M Hoepelman; A C A P Leenders; M H A Hermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

5.  Q fever: baseline monitoring of a sheep and a goat flock associated with human infections.

Authors:  R Eibach; F Bothe; M Runge; S F Fischer; W Philipp; M Ganter
Journal:  Epidemiol Infect       Date:  2012-01-05       Impact factor: 2.451

6.  Large regional differences in serological follow-up of Q fever patients in the Netherlands.

Authors:  Gabriëlla Morroy; Cornelia C H Wielders; Mandy J B Kruisbergen; Wim van der Hoek; Jan H Marcelis; Marjolijn C A Wegdam-Blans; Clementine J Wijkmans; Peter M Schneeberger
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.